
U.S. doctors administered more than 150,000 doses of useless monoclonal antibody treatments to COVID-19 patients early this year, spending loads of cash on therapies that had been deemed of no benefit, a new study has found. The U.S. Food and Drug Administration deauthorized the use of two COVID monoclonal antibody treatments in January, after it… read on > read on >